{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:38:19Z","timestamp":1768322299935,"version":"3.49.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E<jats:sub>2<\/jats:sub> (PGE2) is a chief mediator of inflammation. However, the role and mechanism of mPGES-1 in peritoneal dialysis (PD)-associated peritoneal fibrosis have not been investigated.<\/jats:p><jats:p><jats:bold>Material and Methods:<\/jats:bold> In PD patients, mPGES-1 expression in peritoneum tissues and the levels of PGE2, IL-1\u03b2, and IL-18 in the dialysate were examined. In rat peritoneal mesothelial cells (RPMCs), the regulation and function of mPGES-1 and NLRP3 inflammasome were investigated. The expression of extracellular matrix proteins and the components of NLRP3 inflammasome were detected by Western blotting or real-time quantitative PCR.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In PD patients with ultrafiltration failure (UFF), mPGES-1 was enhanced in the peritoneum, which was associated with the degree of peritoneal fibrosis. Accordingly, the intraperitoneal PGE2 levels were also positively related to the PD duration, serum C-reactive protein levels, and serum creatinine levels in incident PD patients. In RPMCs, high-glucose treatment significantly induced mPGES-1 expression and PGE2 secretion without affecting the expressions of mPGES-2 and cPGES. Inhibition of mPGES-1 via short hairpin RNA significantly ameliorated the expression of extracellular matrix proteins of RPMCs induced by high glucose. Additionally, high glucose markedly activated NLRP3 inflammasome in RPMCs that was blunted by mPGES-1 inhibition. Furthermore, silencing NLRP3 with siRNA significantly abrogated the expression of extracellular matrix proteins in RPMCs treated with high glucose. Finally, we observed increased IL-1\u03b2 and IL-18 levels in the dialysate of incident PD patients, showing a positive correlation with PGE2.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> These data demonstrate that mPGES-1-derived PGE2 plays a critical role in PD-associated peritoneal fibrosis through activation of the NLRP3 inflammasome. Targeting mPGES-1 may offer a novel strategy to treat peritoneal fibrosis during PD.<\/jats:p>","DOI":"10.3389\/fmed.2021.675363","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T10:57:03Z","timestamp":1621335423000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Enhanced mPGES-1 Contributes to PD-Related Peritoneal Fibrosis via Activation of the NLRP3 Inflammasome"],"prefix":"10.3389","volume":"8","author":[{"given":"Qimei","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingkun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongle","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianrui","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrneph.2013.146","article-title":"Nephrology in China","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00467-007-0541-z","article-title":"Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis","volume":"23","author":"Fusshoeller","year":"","journal-title":"Pediatr Nephrol. ("},{"key":"B3","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semnephrol.2011.01.006","article-title":"Determinants of peritoneal membrane function over time","volume":"31","author":"Davies","year":"2011","journal-title":"Semin Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"484167","DOI":"10.1155\/2012\/484167","article-title":"Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells","volume":"2012","author":"Yung","year":"2012","journal-title":"Mediat Inflamm."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1681\/ASN.2014090939","article-title":"Interstitial fibrosis restricts osmotic water transport in encapsulating peritoneal sclerosis","volume":"26","author":"Morelle","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/089686080702702s12","article-title":"Mediators of inflammation and fibrosis","author":"Lai","year":"2007","journal-title":"Perit Dial Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"F198","DOI":"10.1152\/ajprenal.00293.2012","article-title":"Isolation of interstitial fluid and demonstration of local proinflammatory cytokine production and increased absorptive gradient in chronic peritoneal dialysis","volume":"304","author":"Rosengren","year":"2013","journal-title":"Am J Physiol Renal Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/ndt\/gfv440","article-title":"Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL fluid study","volume":"31","author":"Lambie","year":"2016","journal-title":"Nephrol Dial Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11255-016-1430-9","article-title":"The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells","volume":"49","author":"Choi","year":"2017","journal-title":"Int Urol Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3389\/fphys.2017.00762","article-title":"Proinflammatory effect of high glucose concentrations on HMrSV5 cells via the autocrine effect of HMGB1","volume":"8","author":"Chu","year":"2017","journal-title":"Front Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3543678","DOI":"10.1155\/2016\/3543678","article-title":"Molecular mechanisms underlying peritoneal EMT and fibrosis","volume":"2016","author":"Strippoli","year":"2016","journal-title":"Stem Cells Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.4155\/fmc.11.136","article-title":"Identification and development of mPGES-1 inhibitors: where we are at?","volume":"3","author":"Chang","year":"2011","journal-title":"Future Med Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2796.2008.01938.x","article-title":"Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease","volume":"263","author":"Wang","year":"2008","journal-title":"J Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1161\/CIRCULATIONAHA.110.973685","article-title":"Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury","volume":"123","author":"Wang","year":"2011","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"33684","DOI":"10.1074\/jbc.M400199200","article-title":"Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1","volume":"279","author":"Kamei","year":"2004","journal-title":"J Biol Chem."},{"key":"B17","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1681\/ASN.V9112005","article-title":"High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity","volume":"9","author":"Sitter","year":"1998","journal-title":"J Am Soc Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1681\/ASN.2016070729","article-title":"The NLRP3 inflammasome has a critical role in peritoneal dialysis-related peritonitis","volume":"28","author":"Hautem","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000499604","article-title":"Prostaglandin E2 regulates activation of mouse peritoneal macrophages by staphylococcus aureus through toll-like receptor 2, toll-like receptor 4, and NLRP3 inflammasome signaling","volume":"12","author":"Wu","year":"2020","journal-title":"J Innate Immun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000368972","article-title":"Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach","volume":"39","author":"Teitelbaum","year":"2015","journal-title":"Blood Purif."},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-60761-849-2_5","article-title":"Principles and methods of immunohistochemistry","volume":"691","author":"Ramos-Vara","year":"2011","journal-title":"Methods Mol Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.vetimm.2017.09.008","article-title":"Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE2 in an in vitro equine inflammation model","volume":"192","author":"Martin","year":"2017","journal-title":"Vet Immunol Immunopathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1111\/bph.13939","article-title":"Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI2 : a safer alternative to COX-2 inhibition","volume":"174","author":"Ozen","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/labinvest.3700200","article-title":"Microsomal prostaglandin E synthase (mPGES)-1, mPGES-2 and cytosolic PGES expression in human gastritis and gastric ulcer tissue","volume":"85","author":"Gudis","year":"2005","journal-title":"Lab Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bcp.2017.07.010","article-title":"Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis","volume":"142","author":"Zhou","year":"2017","journal-title":"Biochem Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3389\/fimmu.2018.02954","article-title":"mPGES-1-mediated production of PGE2 and EP4 receptor sensing regulate T cell colonic inflammation","volume":"9","author":"Maseda","year":"2018","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"F121","DOI":"10.1152\/ajprenal.00231.2016","article-title":"Deficiency of mPGES-1 exacerbates renal fibrosis and inflammation in mice with unilateral ureteral obstruction","volume":"312","author":"Luo","year":"2017","journal-title":"Am J Physiol Renal Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/HYPERTENSIONAHA.118.10833","article-title":"mPGES-1 (Microsomal Prostaglandin E Synthase-1) mediates vascular dysfunction in hypertension through oxidative stress","volume":"72","author":"Avendano","year":"2018","journal-title":"Hypertension."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.18632\/oncotarget.24187","article-title":"Mitochondrial oxidative stress activates COX-2\/mPGES-1\/PGE2 cascade induced by albumin in renal proximal tubular cells","volume":"9","author":"Zhuang","year":"2018","journal-title":"Oncotarget."},{"key":"B30","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/ar3226","article-title":"mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis","volume":"13","author":"McCann","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/oxfordjournals.ndt.a027318","article-title":"Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis","volume":"11","author":"Davies","year":"1996","journal-title":"Nephrol Dial Transpl."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1681\/ASN.2013030314","article-title":"Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival","volume":"24","author":"Lambie","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/089686080602600109","article-title":"Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis","volume":"26","author":"Pecoits-Filho","year":"2006","journal-title":"Perit Dial Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e93063","DOI":"10.1371\/journal.pone.0093063","article-title":"High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients","volume":"9","author":"Liu","year":"2014","journal-title":"PloS ONE."},{"key":"B35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1248\/bpb.b16-01026","article-title":"The role of mPGES-1 in inflammatory brain diseases","volume":"40","author":"Ikeda-Matsuo","year":"2017","journal-title":"Biol Pharm Bull."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3389\/fphys.2018.01358","article-title":"Invalidation of microsomal prostaglandin E synthase-1 (mPGES-1) reduces diet-induced low-grade inflammation and adiposity","volume":"9","author":"Pierre","year":"2018","journal-title":"Front Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2018.05.010","article-title":"Inhibition of COX-2\/mPGES-1 and 5-LOX in macrophages by leonurine ameliorates monosodium urate crystal-induced inflammation","volume":"351","author":"Liu","year":"2018","journal-title":"Toxicol Appl Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1055\/a-0664-0699","article-title":"Prostaglandin E2 activates NLRP3 inflammasome in endothelial cells to promote diabetic retinopathy","volume":"50","author":"Wang","year":"2018","journal-title":"Horm Metab Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.yexcr.2016.01.014","article-title":"The role of resveratrol-induced mitophagy\/autophagy in peritoneal mesothelial cells inflammatory injury via NLRP3 inflammasome activation triggered by mitochondrial ROS","volume":"341","author":"Wu","year":"2016","journal-title":"Exp Cell Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.freeradbiomed.2016.07.014","article-title":"Angiotensin (1-7) attenuated angiotensin II-induced hepatocyte EMT by inhibiting NOX-derived H2O2-activated NLRP3 inflammasome\/IL-1beta\/Smad circuit","volume":"97","author":"Zhang","year":"2016","journal-title":"Free Radic Biol Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.675363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T10:57:05Z","timestamp":1621335425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.675363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":40,"alternative-id":["10.3389\/fmed.2021.675363"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.675363","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"article-number":"675363"}}